[Clinical surveillance of patients with multiple sclerosis].
Clinical management of people with multiple sclerosis (MS) is based not only on the control of side-effects of disease-modifying drugs but also on the recognition and treatment of disease exacerbations, on the evaluation of disease progression and on the management of the wide range of MS symptoms. A multidisciplinary approach is essential to achieve the best results and improve the quality of life of MS patients.
Cazzato
Giuseppe
G
Zorzon
Marino
M
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D018450:Disease Progression; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000523:psychology; D010348:Patient Care Team; D010455:Peptides / Q000627:therapeutic use; D011159:Population Surveillance; D011788:Quality of Life; D012008:Recurrence
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta